Showing results (471-480 of 689) with videos related to
Sort By:
Pageof 69
Archives of Dermatology|June 1, 1988
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow supportT C Shea, K H Antman, J P Eder, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 26, 2022
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trialSiddharth M Patel, Michael G Palazzolo, Sabina A Murphy, et al.JACC. Advances|February 26, 2026
Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making: ENGAGE AF-TIMI 48 Trial AnalysisC Michael Gibson, Cathy Chen, Jacqueline Buros-Novik, et al.International Journal of Cardiology|May 1, 1989
Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study GroupE M Antman, W D Dupont, J Bonalsky, et al.Circulation|July 4, 2018
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 TrialOphelia Q P Yin, Elliott M Antman, Eugene Braunwald, et al.JACC. Clinical Electrophysiology|April 26, 2023
Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure PhenotypesRiccardo M Inciardi, Robert P Giugliano, Jeong-Gun Park, et al.Circulation|December 28, 2018
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48David D Berg, Christian T Ruff, Petr Jarolim, et al.European Journal of Human Genetics : EJHG|December 4, 2025
Reconsidering a silent variant: SGCA's role in atypical cardiomyopathySmadar Horowitz-Cederboim, Ronit Hoffman-Lipschuetz, Ronen Durst, et al.Circulation|May 7, 2014
Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply: a conference report from the American Heart Association Sodium Conference 2013 Planning GroupElliott M Antman, Lawrence J Appel, Douglas Balentine, et al.International Journal of Cardiology|June 20, 2017
First experience with edoxaban and atrial fibrillation ablation - Insights from the ENGAGE AF-TIMI 48 trialJan Steffel, Christian T Ruff, Rose A Hamershock, et al.Pageof 69